A smoking cessation program as a resource for bladder cancer patients
DOI:
https://doi.org/10.5489/cuaj.16Abstract
Background: Continued tobacco use following a bladder cancer(CaB) diagnosis puts patients at risk for other tobacco-associateddiseases and has also been associated with heightened risks oftreatment-related complications, tumour recurrence, morbidity andmortality. Our aim was to determine if patients with CaB who continueto smoke warrant a smoking cessation program as a resourcefor improving their prognosis and long-term health.
Methods: A cross-sectional quantitative questionnaire-based studywas performed between January and April 2009. We surveyedpatients with a pathologically confirmed diagnosis of CaB duringtheir cystoscopy appointments at a single cancer centre.
Results: One hundred patients completed the survey with 72% ofthem admitting to smoking in their lifetime. A third of respondentssmoked at the time of their diagnosis; 76% of patients who hadbeen active smokers at the time of their diagnosis (n = 33) reportedsmoking at some point thereafter and 58% continued to smoke. Among continued smokers, they were classified in the following categories: 26% were in “precontemplation,” 5% in “contemplation,”16% in “preparation,” and 53% in “action;” 37% of patientswho continued to smoke were interested in a hospital-based smokingcessation program. Overall, 70% reported smoking as a risk factor for a poor CaB prognosis. The two most common barriersto quitting were “trouble managing stress and mood” and “fear ofgaining weight.”
Conclusion: Based on the data from our centre, patients with CaBwho continue to smoke after their diagnosis warrant a smoking cessationprogram as a resource for improving prognosis and long-term health. Further research should focus on establishing an efficacious and cost-effective program that provides these patients with theresources they need to quit smoking.
Downloads
References
Canadian Cancer Society’s Steering Committee: Canadian Cancer Statistics 2009, Toronto. Canadian
Cancer Society, 2009. www.cancer.ca/statistics. Accessed April 11, 2011.
Cagiannos I, Morash C. Surveillance strategies after definitive therapy of invasive bladder cancer. Can
Urol Assoc J 2009;3:S237-42.
Ehdaie B, Smith SC, Theodorescu D. Personalized medicine in advanced urothelial cancer: when to treat,
how to treat and who to treat. Can Urol Assoc J 2009;3:S232-6.
Fradet Y. Screening for bladder cancer: the best opportunity to reduce mortality. Can Urol Assoc J
;3:S180-3.
Nepple KG, O’Donnell MA. The optimal management of T1 high-grade bladder cancer. Can Urol Assoc J 2009;3:S188-92.
Yafi FA, Kassouf W. Radical cystectomy is the treatment of choice for invasive bladder cancer. Can Urol Assoc J 2009;3:409-12.
Cohen SM, Johansson SL. Epidemiology and etiology of bladder cancer. Urol Clin North Am 1992;19:421-
Strope SA, Montie JE. The causal role of cigarette smoking in bladder cancer initiation and progression,
and the role of urologists in smoking cessation. J Urol 2008;180:31-7; discussion 37.
Colin P, Koenig P, Ouzzane A, et al. Environmental factors involved in carcinogenesis of urothelial cell
carcinomas of the upper urinary tract. BJU Int 2009;104:1436-40.
Baris D, Karagas MR, Verrill C, et al. A case-control study of smoking and bladder cancer risk: emergent
patterns over time. J Natl Cancer Inst 2009;101:1553-61.
Nieder AM, MacKinnon JA, Fleming LE, et al. Bladder cancer clusters in Florida: identifying populations at
risk. J Urol 2009;182:46-50; discussion 51.
Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes
of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer
;86:2337-45.
Kamat AM, Lotan YR. Perioperative Intravesical Therapy after transurethral resection for bladder cancer.
J Urol 2010;183:19-20.
Lund L, Jacobsen J, Clark P, et al. Impact of comorbidity on survival of invasive bladder cancer patients,
-2007: A Danish population-based cohort study. Urology 2010 75:393-8. Epub 2009 Nov 14.
Dresler CM, Leon ME, Straif K, et al. Reversal of risk upon quitting smoking. Lancet 2006;368:348-9.
Del Rey J, Placer J, Vallmanya F, et al. Are patients with non-muscle-invasive bladder cancer a suitable
population for a lung cancer screening trial? BJU Int 2010;106:49-52. Epub 2009 Nov 17.
Byrne MM, Davila EP, Zhao W, et al. Cancer screening behaviors among smokers and non-smokers. Cancer
Epidemiol 2010;34:611-7. Epub 2010 Jul 23.
Ostroff J, Garland J, Moadel A, et al. Cigarette smoking patterns in patients after treatment of bladder
cancer. J Cancer Educ 2000;15:86-90.
Hay JL, Ostroff J, Burkhalter J, et al. Changes in cancer-related risk perception and smoking across time
in newly-diagnosed cancer patients. J Behav Med 2007;30:131-42.
Nieder AM, John S, Messina CR, et al. Are patients aware of the association between smoking and bladder
cancer? J Urol 2006;176:2405-8; discussion 2408.
Dearing J. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder.
Ann R Coll Surg Engl 2005;87:85-7.
Centers for Disease Control and Prevention (USA). Behavioral Risk Factor Surveillance System Questionnaire;
December 31, 2007.
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot
;12:38-48.
Lotan Y, Elias K, Svatek RS, et al. Bladder cancer screening in a high risk asymptomatic population using
a point of care urine based protein tumor marker. J Urol 2009;182:52-7; discussion 58.
Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15:352-8.
Logan HL, Fillingim RB, Bartoshuk LM, et al. Smoking status and pain level among head and neck cancer
patients. J Pain 2010;11:528-34.
Cowling DW, Yang J. Smoking-attributable cancer mortality in California, 1979-2005. Tob Control 2010;19
(Suppl 1):i62-7.
Canadian Cancer Society. One Step at a Time. http://www.cancer.ca/Ontario/Publications.aspx?sc_
lang=en. Accessed April 11, 2011.
Velicer W, Prochaska J, Fava J, et al. Smoking cessation and stress management: applications of the
transtheoretical model of behavior change. Homeostasis 1998;38.
Coleman T. ABC of smoking cessation. Use of simple advice and behavioural support. BMJ 2004;328:397-9.
Ministry of Health and Long Term Care (Ontario-Canada). The Ottawa Model for Smoking Cessation,
a network’s success: simply smoke free. http://www.health.gov.on.ca/english/providers/program/
cdpm/pdf/ottawa.pdf . Accessed April 11, 2011.
Ministry of Health Promotion. (Ontario-Canada). News Release: McGuinty Government Supports Innovative
Smoking Cessation Program. http://www.mhp.gov.on.ca/en/news/2005/110905.asp. Accessed April 11, 2011.
Downloads
Published
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.
